Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 9

Results: 11

Cover Image, Volume 43, Issue 9.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. i, doi. 10.1002/cac2.12483

By:

Shi, Yaoping;
Shi, Donghua;
Chi, Jiachang;
Cui, Dan;
Tang, Xiaoyin;
Lin, Yan;
Wang, Siying;
Li, Zonghai;
Jin, Haojie;
Zhai, Bo

Publication type:

Article

Uncovering the IL‐1β‐PCAF‐NNT axis: A new player in ferroptosis and tumor immune evasion.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1048, doi. 10.1002/cac2.12473

By:

Li, Qidong;
Gan, Boyi

Publication type:

Article

Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1064, doi. 10.1002/cac2.12472

By:

Shi, Yaoping;
Shi, Donghua;
Chi, Jiachang;
Cui, Dan;
Tang, Xiaoyin;
Lin, Yan;
Wang, Siying;
Li, Zonghai;
Jin, Haojie;
Zhai, Bo

Publication type:

Article

Bifidobacterium adolescentis orchestrates CD143<sup>+</sup> cancer‐associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling‐regulated GAS1.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1027, doi. 10.1002/cac2.12469

By:

Chen, Shujie;
Fan, Lina;
Lin, Yifeng;
Qi, Yadong;
Xu, Chaochao;
Ge, Qiwei;
Zhang, Ying;
Wang, Qiwen;
Jia, Dingjiacheng;
Wang, Lan;
Si, Jianmin;
Wang, Liangjing

Publication type:

Article

Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1003, doi. 10.1002/cac2.12465

By:

Chen, Xin‐Yu;
Li, Bin;
Wang, Ye;
Jin, Juan;
Yang, Yu;
Huang, Lei‐Huan;
Yang, Meng‐Di;
Zhang, Jian;
Wang, Bi‐Yun;
Shao, Zhi‐Ming;
Ni, Ting;
Huang, Sheng‐Lin;
Hu, Xi‐Chun;
Tao, Zhong‐Hua

Publication type:

Article

HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress‐driven hepatocellular carcinoma progression.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 981, doi. 10.1002/cac2.12464

By:

He, Lin;
Li, Hao;
Li, Can;
Liu, Ze‐Kun;
Lu, Meng;
Zhang, Ren‐Yu;
Wu, Dong;
Wei, Ding;
Shao, Jie;
Liu, Man;
Wei, Hao‐Lin;
Zhang, Cong;
Wang, Zhe;
Kong, Ling‐Min;
Chen, Zhi‐Nan;
Bian, Huijie

Publication type:

Article

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1051, doi. 10.1002/cac2.12461

By:

Blanchi, Julie;
Taleb, Sofiane;
Bayle, Arnaud;
Verret, Benjamin;
Toulmonde, Maud;
Spalato‐ceruso, Mariella;
Dubos, Paul;
Laizet, Yech'an;
Alame, Melissa;
Khalifa, Emmanuel;
Italiano, Antoine

Publication type:

Article

Worldwide trends in esophageal cancer survival, by sub‐site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000‐2014 (CONCORD‐3).

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 963, doi. 10.1002/cac2.12457

By:

Matz, Melissa;
Valkov, Mikhail;
Šekerija, Mario;
Luttman, Sabine;
Caldarella, Adele;
Coleman, Michel P;
Allemani, Claudia

Publication type:

Article

A phase II study on Mefatinib as first‐line treatment of patients with advanced non‐small‐cell lung cancer harboring uncommon EGFR mutations.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1059, doi. 10.1002/cac2.12456

By:

Wang, Pingli;
Cao, Liming;
Tian, Panwen;
Ren, Shengxiang;
Miao, Liyun;
Zhou, Chengzhi;
Fan, Yun;
Li, Yuping;
Lv, Dongqing;
Zhao, Xin;
Yang, Mei;
Zhu, Chaonan;
Yu, Bing;
Xu, June;
Song, Yong;
Wang, Kai

Publication type:

Article

Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions.

Published in:

Cancer Communications, 2023, v. 43, n. 9, p. 1055, doi. 10.1002/cac2.12451

By:

Li, Chunbo;
Hua, Keqin

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2023, v. 43, n. 9, p. 961, doi. 10.1002/cac2.12306
Publication type:: Article